• Abstract Title: An abstract must have a short, specific presentation title (containing no abbreviations) that indicates the nature of the presentation. Titles should read as you want them to appear in meeting publications. Use title case capitalization, do not use all CAPITAL LETTERS and do not put a period at the end of the title. Example: This is a Properly Formatted Abstract Title  

• Presenting Author (Lead Author): Individual submitting the abstract.
  • The Presenting Author is required to register and attend the meeting. 
  • The Presenting Author is expected to present (if applicable).
  • Note: e-Posters do not have an oral presentation requirement.
  • The Presenting Author must submit under one’s own account.
  • The Presenting Author’s account information/status (at the time of submission) is used to determine award eligibility.
  • All correspondence with the Presenting Author is done via email.  

Co-Authors: A co-author is an individual who helped you work on the abstract or someone that you would like to recognize in creation of the submission may be included as a co-author. List their full names with credentials and email addresses. All authors must be added to submissions before the deadline. Additional authors cannot be added to the submission after Saturday, October 18, 2025, 11:59 pm CT.

Disclosure: Disclosure is required for the presenting author, as well as agreement with the Terms and Conditions.

Topic Categories: APP, Cerebrovascular, Education, History, Pain, Pediatrics, Peripheral Nerve, Socioeconomic, Spine, Stereotactic and Functional, Trauma and Critical Care, Tumor.

Abstract Body: Include introduction, methods, results and conclusion sections. Text is limited to 320 words.

Additional Information: This includes elements such as previous presentation of the abstract, FDA approval, industry employment status, medical student/resident designation, senior author information, funding/database questions and award consideration. Review Work: You may review your abstract by selecting “Preview Abstract. “Proofread all abstracts before they are submitted to avoid errors. Once reviewed, hit the save submission button to confirm all tasks have been completed.

Submit: All tasks must be completed, and the abstract status must read “COMPLETE” on the submission site home screen for the abstract to be included in grading. Make sure to complete your abstract by hitting the submit button. A confirmation email will be sent.

 

Note: Abstracts cannot contain advertising, trade names or product-group messaging. Include generic names or terms in your abstract content. If the abstract includes trade names, names from several companies should be used — not just trade names from a single company — to present all available treatment options. If trade names or company names are included in your abstract, the AANS reserves the right to remove them to ensure all scientific content is free from commercial bias.